Hua et al. [18] determined a crystal structure of human CB1R in complex with the designed antagonist, AM6538, whereas Shao et al. [17] generated crystal structure of CB1R by binding the anti-obesity drug taranabant (Table 1). The gene discussed is CNR1; the disease is obesity disorder.